The recent marketing of trimethoprim (TMP) as a single drug has resulted in interest in the use of this drug to treat common infections. The history and antibacterial properties of TMP are reviewed. Indications for the clinical use of TMP are presented, and possible new uses for the drug are considered. The significance of adverse effects is discussed. The pharmacokinetic properties of TMP are reviewed with particular emphasis on the renal handling of the drug and its advantages over TMP/sulfonamide combinations in relation to renal function and toxicity.
BushbySRM. Combined antibacterial action in vitro of trimethoprim and sulfonamides. Postgrad Med J1969; 45 (Suppl): 10–18.
2.
BurchallJJ. Mechanism of action of trimethoprim-sulphamethoxazole, II. J Infect Dis1973; 128(Suppl): S437–41.
3.
PoeM. Antibacterial synergism: A proposal for chemotherapeutic potentiation between trimethoprim and sulfamethoxazole. Science1976; 194: 533–5.
4.
GrünebergE. The effect of trimethoprim on the activity of sulfonamides and antibiotics in experimental infections. J Infect Dis1973; 128(Suppl): S478–85.
5.
GreenwoodD. Relevance of in vitro synergy to therapy: Does synergy between diaminopyrimidines and sulphonamides operate at concentrations available in the urine?J Antimicrob Ther1979; 5(Suppl): 85–9.
6.
AndersonJDLaceyRWLewisELSellinMA. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model in the urinary tract. J Clin Pathol1974; 27: 619–22.
7.
LewisELAndersonJDLaceyRW. A reappraisal of the antibacterial action of co-trimoxazole in vitro. J Clin Pathol1974; 27: 87–91.
KasanenAAnttilaMElfvingR, Trimethoprim. Pharmacology, antimicrobial activity, and clinical use in urinary tract infections. Ann Clin Res1978; 10 (22 suppl): 1–39.
10.
MearesEM. Observations on activity of trimethoprim-sulphamethoxazole in the prostate. J Infect Dis1973; 128(Suppl): 679–85.
11.
HillsNHBultitudeMIEykynS. Co-trimoxazole in prevention of bacteriuria after prostatectomy. Br Med J1976; 2: 498–9.
12.
BrumfittWPursellR. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection. Br Med J1972; 2: 673–5.
13.
KochVJSchumannKPKuchlerRKewitzH. Efficacy of trimethoprim, sulphamethoxazole, and the combination of both in acute urinary tract infections. Chemotherapy1973; 19: 314–22.
14.
KasanenASundquistHJunnilaSYT. Trimethoprim in the treatment of acute urinary tract infection. Curr Ther Res1979; 25: 202–9.
15.
LaceyRWLordVLGunasekeraHKWLiebermanPJLuxtonDEA. Comparison of trimethoprim alone with trimethoprim-sulphamethoxazole in the treatment of respiratory and urinary tract infections with particular reference to selection of trimethoprim resistance. Lancet1980; 1: 1270–3.
16.
FriesenWTHeksterYABoeremaJBJVreeTBNiesteHLJvan der KleijnE. Recent developments in the treatment of acute urinary tract infections. J Hosp Clin Pharm1981; 35: 1–30.
17.
HansenIBLykkegaardNHeerfordtL, Trimethoprim in normal and pathological human lung tissue. Chemotherapy1973; 19: 221–34.
18.
Trimethoprim-sulfamethoxazole for otitis media. Med Letter Drug Ther1978; 20: 59–60.
19.
CsonkaGWKnightGJ. Therapeutic trial of trimethoprim as a potentiator of sulfonamides in gonorrhoea. Br J Vener Dis1967; 43: 161–5.
20.
AustinTWBrooksGFBethelMRobertsFLTurckMHolmesKK. Trimethoprim-sulphamethoxazole in the treatment of gonococcal urethritis: Clinical and laboratory correlates. J Infect Dis1973; 128(Suppl): 666–72.
21.
GilmanRHTerminelMLevineMM, Comparison of trimethoprim-sulphamethoxazole and amoxycillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever. J Infect Dis1975; 132: 630–6.
BuskHEKornerB. Trimethoprim resistance in Finland. Br Med J1980; 7: 1054–5.
24.
BurmanLJ. Resistance to trimethoprim. Lancet1980; 1: 1409.
25.
ArioliVMBertiGCarnitiGSilvestriLG. Interactions between rifampicin and trimethoprim in combination. J Antimicrob Chemother1977; 3: 87–94.
26.
BrumfittWHamilton-MillerJMT. The possible clinical value of rifampicin and trimethoprim in combination. Infection1978; 6(Suppl): 53–6.
27.
BrumfittWCooperJHamilton-MillerJ. Rifaprim® (rifampin plus trimethoprim): A comparative trial with cephradine in patients with recurrent urinary tract infection. In: NelsonJDGrassiC, eds. Current chemotherapy and infectious disease. Washington: American Society for Microbiology, 1980: 430–2.
28.
ParsleyTLProvoncheeRBGlicksmanCZinnerSH. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli. Antimicrob Agents Chemother1977; 12: 349–52.
29.
PaisleyJWWashingtonJA. Synergistic activity of gentamicin with trimethoprim and trimethoprim-sulphamethoxazole against Escherichia coli and Klebsiella pneumoniae. Antimicrob Agents Chemother1978; 14: 656–8.
30.
RubinRHSwartzMN. Trimethoprim-sulphamethoxazole. N Engl J Med1980; 303: 426–32.
31.
GleckmanRAlvarezSJoubertDW. Drug therapy reviews: Trimethoprim-sulphamethoxazole. Am J Hosp Pharm1979; 36: 893–906.
32.
BernsteinLSCooperJ. Co-trimoxazole and Stevens-Johnson syndrome. Lancet1978; 1: 988.
33.
KouttsJVan der WeydenMBCooperM. Effect of trimethoprim on folate metabolism in human bone marrow. Aust NZ J Med1973; 3: 245–9.
VreeTBHeksterYAvan DalenR. Het meten van de concentratie van Sulfonamiden in bloed en urine van patienten met gestoorde nierfunktie. Folia Chemother1981; in press.
36.
BerglungFKillanderJPompeiusR. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol1975; 114: 802–8.
37.
BaileyRRLittlePJ. Deterioration in renal function in association with co-trimoxazole therapy. Med J Aust1976; 1: 914–8.
SchwartzDEZeiglerWH. Assay and pharmacokinetics of trimethoprim in man and animals. Postgrad Med J1969; 45(Suppl): 32–7.
40.
KremersPDuvivierJHeusghemC. Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses. J Clin Pharmacol1974; 14: 112–7.
41.
VreeTBHeksterYABaarsAMDamsmaJEvan der KleijnE. Determination of trimethoprim and sulphamethoxazole (co-trimoxazole) in body fluids of man by means of high performance liquid chromatography. J Chromatog1978; 146: 103–12.
42.
ReevesDSWilkinsonPJ. The pharmacokinetics of trimethoprim and trimethoprim/sulfonamide combinations, including penetration into body tissues. Infection1979; 7(Suppl 4): S330–41.
43.
SchwartzDERiederJ. Pharmacokinetics of sulphamethoxazole and trimethoprim in man and animals. Chemotherapy1970; 15: 337–55.
44.
RiederJ. Metabolism and techniques for assay of trimethoprim and sulfamethoxazole. J Infect Dis1973; 128 (Suppl): 567–73.
45.
SigelCWGraceMENicholCA. Metabolism of trimethoprim in man and measurement of a new metabolite. A new fluorescent assay. J Infect Dis1973; 128(Suppl): 580–3.
46.
WeinfeldREMacasiebTC. Determination of trimethoprim in biological fluids by high performance liquid chromatography. J Chromatog1979; 164: 73–84.
47.
SharpstoneP. The renal handling of trimethoprim and sulphamethoxazole in man. Postgrad Med J1969; 45 (Suppl): 38–42.
48.
BerganTBrodwallEK. Kidney transport in man of sulphamethoxazole and trimethoprim. Chemotherapy1972; 17: 320–33.
49.
CraigWKuninC. Trimethoprim-sulfamethoxazole: Pharmacodynamic effects of urinary pH and impaired renal function: Studies in humans. Ann Intern Med1973; 79: 491–7.
